EGFR and lung carcinoma: Based on molecular modeling techniques and their importance in computer-aided drug design (CADD) [52,53], we performed a comprehensive screening of 50 phytochemicals to determine their bioavailability, pharmacokinetics/pharmacodynamics, and their likely interactions with the Epidermal growth factor receptor tyrosine kinase domain (EGFR-TKD) involved in the proliferation of breast and lung cancer cell lines and several other types of cancer [[54], [55], [56]].